Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Adverse Event Treatment	NCIT_C88082
Type of Report Information	NCIT_C88083
Observation ICSR Terminology	NCIT_C88088	[Terminology used in Individual Case Safety Reports for observations related to reporting adverse events.]
Stage 0 Distal Bile Duct Cancer AJCC v7	NCIT_C88089	[Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Ovarian Serous Adenocarcinoma	NCIT_C7550	[An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.]
Malignant Ovarian Serous Tumor	NCIT_C40025	[An invasive malignant neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia. It includes serous adenocarcinoma and serous adenocarcinofibroma.]
Stage III Prostate Cancer AJCC v6	NCIT_C7551	[Stage III includes: T3, N0, M0, Any G. T3: Tumor extends through the prostatic capsule. T3a: Extracapsular extension (unilateral or bilateral). T3b: Tumor invades seminal vesicle(s). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003]
Stage C Prostate Cancer	NCIT_C7552	[Tumor is clinically localized to the periprostatic area, but extends through the prostatic capsule; the seminal vesicles may be involved. -- 2004]
Used According to Label Indicator	NCIT_C88084
ICSR Assigned Entity Person Role Code	NCIT_C88085
ICSR Assigned Entity Organization Role Code	NCIT_C88086
Primary Source Reporter	NCIT_C88087
Reporter	NCIT_C41191	[Somebody who makes a report of any kind, e.g. a person who is authorized to gather and give a formal or official account or description of findings, events, issues and other information regarding clinical study, drug adverse effect, preclinical research results, data and safety monitoring, etc. to appropriate agency or institution.]
Hidradenoma	NCIT_C7563	[A benign epithelial neoplasm arising from the sweat glands. Variants include the clear cell and nodular hidradenoma.]
Thymic Epithelial Neoplasm	NCIT_C6450	[An epithelial neoplasm that affects the thymus gland. This category includes thymomas and carcinomas.]
Eccrine Hidrocystoma	NCIT_C7565	[A benign sweat gland cystic lesion that arises from the dermis. It is lined by a thin epithelial layer of cells with a slightly eosinophilic cytoplasm.]
Hidrocystoma	NCIT_C3760	[A benign cystic proliferation of the sweat glands with apocrine or eccrine differentiation. It usually presents as a dome-shaped, cystic papular or nodular lesion usually in the face and neck. It is a unilocular or mutlilocular lesion lined by an inner and an outer layer of epithelium. Complete excision is usually curative.]
Benign Eccrine Neoplasm	NCIT_C6797	[A non-metastasizing eccrine appendage sweat gland neoplasm. Representative examples include hidrocystoma, syringoma, and syringofibroadenoma.]
Sporadic Breast Carcinoma	NCIT_C7566	[A carcinoma that arises from the breast and is not caused by inherited genetic mutations.]
Clear Cell Hidradenoma	NCIT_C7567	[An uncommon benign neoplasm of the sweat glands characterized by the presence of clear cells.]